Vertex Pharmaceuticals Incorporated
CorpDigest
Vertex Pharmaceuticals Incorporated
Annual Revenue
Last reviewed: 2026-06-08 · By Swet Parvadiya
FY2023 Revenue
$9.9B
▲ 10.4% vs FY2022 ($8.9B)
Vertex Pharmaceuticals Incorporated reported $9.9B in revenue for fiscal year 2023. This represents a growth of 10.4% compared to the 2022 figure of $8.9B. In 2024, revenue increased to $10.7B.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.